p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas. [electronic resource]
Producer: 20140908Description: 128-34 p. digitalISSN:- 1879-0593
- Adult
- Aged
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Carcinoma, Squamous Cell -- drug therapy
- Caspase 3 -- metabolism
- Cisplatin -- therapeutic use
- Cyclin D1 -- metabolism
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- ErbB Receptors -- metabolism
- Female
- Fluorouracil -- therapeutic use
- Humans
- Hypopharyngeal Neoplasms -- drug therapy
- Hypoxia-Inducible Factor 1, alpha Subunit -- metabolism
- Laryngeal Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Proteins -- metabolism
- Prognosis
- Proliferating Cell Nuclear Antigen -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.